John P Clancy MD
Professor, Pediatrics, University of Cincinnati College of Medicine
Join to View Full Profile
3333 Burnet Ave., Ml 2021Cincinnati Children's HospitalCincinnati, OH 45229
Phone+1 513-636-6771
Fax+1 513-636-4615
Dr. Clancy is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Alabama Medical CenterFellowship, Pediatric Pulmonology, 1993 - 1996
University of Virginia Medical CenterResidency, Pediatrics, 1990 - 1993
University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 1990
Certifications & Licensure
OH State Medical License 2011 - 2021
AL State Medical License 1993 - 2011
Clinical Trials
- PTC124 for Cystic Fibrosis Start of enrollment: 2005 Sep 01
- Safety/Tolerability Study of Arikayce™ in Cystic Fibrosis Patients With Chronic Infection Due to Pseudomonas Aeruginosa Start of enrollment: 2008 Jan 01
- Detection of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Activity in Rectal Tissues From Human Subjects Start of enrollment: 2009 Oct 01
Publications & Presentations
PubMed
- 12 citationsElexacaftor/Tezacaftor/Ivacaftor Markedly Reducesin Cystic Fibrosis.Sarah J Morgan, David P Nichols, Windy Ni, Gina Hong, Stephen J Salipante
American Journal of Respiratory and Critical Care Medicine. 2024-11-01 - 7 citationsAirway inflammation accelerates pulmonary exacerbations in cystic fibrosis.Theodore G Liou, Natalia Argel, Fadi Asfour, Perry S Brown, Barbara A Chatfield
Iscience. 2024-03-15 - 9 citationsBuilt environment factors predictive of early rapid lung function decline in cystic fibrosis.Emrah Gecili, Cole Brokamp, Erika Rasnick, Pedro M Afonso, Eleni-Rosalina Andrinopoulou
Pediatric Pulmonology. 2023-05-01
Grant Support
- Clinical CoreNational Institute Of Diabetes And Digestive And Kidney Diseases2007–2011
- Phase 3 Study Evaluating Aztreonam Lysiante For Inhalation In Cystic FibrosisNational Center For Research Resources2007
- Eur-1009-MNational Center For Research Resources2007
- Eur-1008-MNational Center For Research Resources2007
- PTCNational Center For Research Resources2006–2007
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
